ClinicaliQ Trial Snapshot
- Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT07759427.
- What is being tested: Non-invasive mapping technology to identify and eliminate ventricular tachycardia in patients with structural heart disease from previous myocardial infarction, potentially avoiding the need for invasive electrophysiology procedures.
- Patient eligibility overview: The trial targets patients with a history of myocardial infarction who have developed ventricular tachycardia and are suitable candidates for ablation therapy, representing a high-risk population requiring intervention.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Ventricular tachycardia (VT) is an abnormal and dangerous heart rhythm affecting the lower chambers of the heart (the ventricles). Patients with structural heart disease caused by previous heart attacks are at an increased risk of developing VT. Current guidelines recommend that patients who develop this abnormal heart rhythm are considered for invasive catheter ablation (ICA). This is an invasive procedure where specialised catheters and a 3D electro anatomical mapping (EAM) system are used to identify the region of the heart responsible for the VT, which is then treated by tissue…
Eligibility Snapshot
- : * ≥18 years old * Patient with the following: * Evidence of post-myocardial infarction* structural heart disease. * Cardiac CT and/or cardiac MRI scan performed within 6 months. * ICD/CRTD implantation. * Device therapy for VT: at least 1 appropriate ICD shock or 3 ATP episodes within a 6-month period. * Suitable candidate for VT ablation as per NHS standard of care. * Patient agrees to comply with study procedures and be available for routine follow up visits for at least 6 months after enrolment.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.